Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study.
Javier PalauEsther SanchoMagdalena HerreraSol SánchezMaria-Eva Mingot-CastellanoRosa Isabel UpeguiMª José Rodríguez SalazarFátima de la CruzMª Cristina FernándezTomás José González LópezJosé Julio HernándezEduardo RíosMª Fernanda López-FernándezMarta GarcíaJosé-Ángel HernándezMiguel A SanzPublished in: Hematology (Amsterdam, Netherlands) (2017)
Characteristics of Spanish ITP patients are comparable to those from other countries. Although a high response rate to first-line treatments is observed, at 1 year, the disease persists in around one quarter of patients. Overall therapeutic management in Spain conforms to current recommendations, except for an excessive duration of corticosteroids therapy.